Next Article in Journal
Age-Related Diseases and Foods Generating Chlorinative Stress
Next Article in Special Issue
Bone Marrow Mesenchymal Stem-Cell-Derived Exosomes Ameliorate Deoxynivalenol-Induced Mice Liver Damage
Previous Article in Journal
Vitamin D3 and COVID-19 Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Analysis of the Antioxidant, Antidiabetic, Antibacterial, Cytoprotective Potential and Metabolite Profile of Two Endophytic Penicillium spp.

by
Kumar Vishven Naveen
,
Kandasamy Saravanakumar
,
Anbazhagan Sathiyaseelan
and
Myeong-Hyeon Wang
*
Department of Bio-Health Convergence, Kangwon National University, Chuncheon 24341, Republic of Korea
*
Author to whom correspondence should be addressed.
Antioxidants 2023, 12(2), 248; https://doi.org/10.3390/antiox12020248
Submission received: 21 December 2022 / Revised: 16 January 2023 / Accepted: 20 January 2023 / Published: 22 January 2023

Abstract

:
The current study assessed the metabolite abundance, alpha (α)-amylase and α-glucosidase inhibitory, antioxidant, and antibacterial activity of the ethyl acetate extract (EAE) of endophytic Penicillium lanosum (PL) and Penicillium radiatolobatum (PR). A higher extract yield was found in EAE-PR with a total phenolic content of 119.87 ± 3.74 mg of GAE/g DW and a total flavonoid content of 16.26 ± 1.95 mg of QE/g DW. The EAE-PR inhibited α-amylase and scavenged ABTS+ radicals with a half-maximal inhibitory concentration (IC50) of 362.5 and 37.5 µg/mL, respectively. Compared with EAE-PL, EAE-PR exhibited higher antibacterial activity against Gram-positive and Gram-negative pathogens. Treatment with EAE-PR (1000 µg/mL) did not cause significant toxicity in the HEK-293 cell line compared to the control cells (p < 0.05). EAE-PR treatments (250–1000 µg/mL) showed higher cytoprotective effects toward H2O2-stressed HEK-293 cells compared with ascorbic acid (AA). The UHPLC-Q-TOF-MS/MS analysis revealed the presence of thiophene A (C13H8S), limonene (C10H16), and phenylacetic acid (C8H8O2) in EAE-PR. Furthermore, these compounds demonstrated substantial interactions with diabetes (α-amylase and α-glucosidase), oxidative stress (NADPH-oxidase), and bacteria (D-alanine D-alanine ligase)-related enzymes/proteins evidenced in silico molecular docking analysis.

Graphical Abstract

1. Introduction

According to the World Health Organization (WHO), almost 74% of deaths are due to non-communicable diseases (NCDs), including chronic respiratory diseases, cardiovascular diseases, diabetes, and cancer [1]. The NCDs are associated with the free radicals, called reactive oxygen species (ROS) and reactive nitrogen species (RNS), namely hydroxyl (HO˙), alkoxyl (RO˙), peroxyl (ROO˙), superoxide (O2ˉ), nitric oxide (NO˙), and hydrogen peroxide (H2O2), generated by numerous physiological progressions in the body [2]. The ROS and RNS cause unavoidable damage to cellular components (DNA, proteins, enzymes, lipids, carbohydrates, etc.) and living tissues via oxidative damage or oxidative stress, which implicates various inflammatory and degenerative diseases in the biological system, such as mellitus, Alzheimer’s disease, Parkinson’s disease, atherosclerosis, liver cirrhosis, and depression [2,3]. Free radicals are exceptionally unstable and highly reactive molecules as they have unpaired valence electrons in their atoms’ outermost shell and are momentary and interact non-selectively with their neighboring molecules [4,5]. Antioxidants are agents that scavenge free radicals (oxidants) and/or transform ROS/RNS initiators (e.g., hydroperoxides) into non-reactive products. Although some antioxidants are naturally produced in the human body (endogenous), in diseased/deficient conditions antioxidants are required through the diet or supplementation (exogenous) to maintain/establish the redox balance. Therefore, natural antioxidants are preferred over synthetic ones and have attracted researchers’ attention.
Diabetes is one of the main chronic diseases among the NCDs, affecting nearly 537 million adults worldwide. The International Diabetes Federation (IDF) and WHO estimated that the global diabetes prevalence would exceed 783 million people by 2045 [1,6]. Diabetes is characterized by constant hyperglycemia that may result from an immune system attack (autoimmune disease) on pancreatic beta-cells (Type-1) or may be associated with sugar accumulation in the blood and insulin resistance in the body (Type-2) [7]. However, chronic hyperglycemia induces auto-oxidation in glucose and generates free radicals, resulting in microvascular/macrovascular complications and/or apoptosis of endothelial cells, and may induce atherosclerosis, cardiovascular complications, hypertension, retinopathy, and renal disorders [8]. Type-2 diabetes can be controlled by changing lifestyle and dietary habits to balance insulin secretion and blood glucose levels. In addition, inhibiting the activities of certain enzymes that convert dietary polysaccharides and monosaccharides into simple sugars (α-amylase and α-glucosidase) has shown promise in diabetes treatment [9]. For instance, α-amylase and α-glucosidase inhibitors, namely acarbose, miglitol, and voglibose, are used in current diabetic medications; however, they produce gastrointestinal disturbances in hosts [7]. Therefore, bioprospecting of novel α-amylase and α-glucosidase inhibitors with minimal side effects could be vital for type-2 diabetes management. Recently, in the search for new antidiabetic agents, the outcomes of natural product research have been encouraging [7,8,9,10,11].
The discovery and development of therapeutic agents from natural sources have historically relied on plants. However, the authentication, cultivation, and procurement of plant-based compounds are costly, laborious, and time-consuming processes and involve ecological concerns. However, plants accommodate certain microbes (actinomycetes, bacteria, and fungi) asymptomatically within the tissues or intracellular spaces known as endophytes. Endophytic fungi are considered to be polyphyletic groups of microbes that carry a common biosynthetic pathway of secondary metabolites similar to that of plants via stabilizing a mutualistic relationship through metabolic interchange and unique plant–microbe interactions [12]. Among the endophytic fungi, the Penicillium spp. are known to produce antagonist compounds that improve plants’ immunity and the resultant protection against abiotic stress and numerous diseases [13]. Moreover, the secondary metabolites from Penicillium sp. have a high degree of structural diversity, including alkaloids, fatty acids, macrolides, peptides, phenylpropanoids, polysaccharides, polyketides, terpenoids, and other structure classes [14]. In addition, endophytic Penicillium sp.-based compounds are reported to have distinct biological activities and therapeutic applications [15]. In addition, fungal endophytes require a nominal amount of labor and culture media, provide the straightforward isolation of culture-dependent metabolites and simple production scale-up, and are non-toxic to mammalian systems.
In addition to NCDs, common bacterial infections are causing a high mortality rate. In 2019, bacterial infections were associated with one in eight fatalities worldwide [16]. According to the Centers for Disease Control and Prevention (CDC), 48 million individuals are infected by foodborne infections each year in the United States [17]. Escherichia coli, Salmonella sp., Staphylococcus aureus, and Listeria monocytogenes are among the major foodborne pathogens and threaten public health [18]. In that respect, polyphenolics such as phenolic acids exhibit an antibacterial action via alteration of the cell membrane potential through hyperacidification at the plasma membrane interphase and sodium–potassium ATPase pump alteration through intracellular acidification against pathogens [19]. Recent studies have also indicated that polyphenolics derived from endophytic Penicillium sp. have antibacterial effects on Gram-positive and Gram-negative pathogens [20,21,22]. Additionally, some structurally diverse and bioactive metabolites, such as epoxydon, griseofulvin, javanicin, meleagrin, oxyskyrin, and penicillic acid are found in extracts of endophytic Penicillium sp. [15]. Moreover, Nischitha et al. detected bilirubin, diisobutylphthalate, and hexadecanamide in the organic extract of P. pinophilum and reported their antibacterial activity [22].
Considering all these factors, this study aimed to evaluate the antidiabetic, antioxidant, and antibacterial potential of the endophytic Penicillium sp. extract. Thus, the secondary metabolites from two endophytic Penicillium strains (P. lanosum strain AN001 and P. radiatolobatum strain AN003) were extracted, tested for bioactivity, and compared. Additionally, the compounds in the extracts were elucidated using UHPLC-Q-TOF-MS/MS, and we studied the in silico molecular interactions of bioactive compounds with enzymes/proteins associated with diabetes, oxidative stress, and bacteria.

2. Materials and Methods

2.1. Reagents and Consumables

Mueller–Hinton agar (MHA) and Mueller–Hinton broth (MHB) were supplied by KisanBio Co., Ltd. (MB cell), Seoul, Republic of Korea (ROK). Peptone (BactoTM) and potato dextrose agar (PDA; DifcoTM) were obtained from Becton, Dickinson and Company (Franklin Lakes, NJ, USA). Ethyl acetate (EA), ethyl alcohol (EtOH), and L (+)-ascorbic acid (AA) were purchased from Daejung Co., Ltd. (Busan, ROK). Dimethyl sulfoxide (DMSO) was obtained from Duchefa Biochemie (Haarlem, The Netherlands). Dextrose, acarbose (AC), erythromycin (Ery), starch, α-amylase from porcine pancreas, α-glucosidase from Saccharomyces cerevisiae, 3,5-dinitrosalicylic acid (DNS), p-nitrophenyl-α-D-glucopyranoside (PNPG), sodium carbonate (Na2CO3), aluminum chloride (AlCl3), Folin–Ciocalteu’s phenol reagent, potassium acetate (CH3COOK), 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 2,2′-azo-bis(2-amidino propane dihydrochloride (ABAP), thiazolyl blue tetrazolium bromide (MTT), propidium iodide (PI), acridine orange (AO), ethidium bromide (EB), rhodamine-123 (Rh-123), and dichlorofluorescein-diacetate (DCFH-DA) were supplied by Sigma-Aldrich (Yongin, ROK). Fetal bovine serum (FBS) and penicillin–streptomycin (PS) solution were purchased from Hyclone Laboratories (Logan, UT, USA). Phosphate-Buffered Saline (PBS) was obtained from Corning® (Manassas, VA, USA). Dulbecco’s Modified Eagle Medium (DMEM) and Roswell Park Memorial Institute (RPMI) medium were acquired from ThermoFisher Scientific (Seoul, ROK). The human embryonic kidney 293 (HEK-293) cells were procured from the Korean Cell Line Bank (KCLB, Seoul, ROK). Pathogenic bacterial strains, namely Bacillus cereus (ATCC 14579), Staphylococcus aureus (ATCC 19095), Listeria monocytogenes (ATCC 15313), Escherichia coli (ATCC 43888), and Salmonella enterica (ATCC 14028), were supplied by the Korean Culture Center of Microorganisms (KCCM, Seoul, ROK).

2.2. Fungal Culture Medium, Liquid Fermentation, and Metabolites Extraction

The potato dextrose broth (PDB) used for fungal cultivation was prepared according to the earlier report [23] with minor modification. Briefly, the potato infusion was prepared by boiling the sliced potatoes (200 g/L) for 30 min and filtering them using cotton gauze. The potato infusion, dextrose (10 g/L), and peptone (2 g/L) were mixed, the pH was adjusted to 5.1, and the solution was autoclaved at 121°C for 15 min. The formerly isolated endophytic isolates, namely P. lanosum strain AN001 (GenBank accession ID. MW237700) and P. radiatolobatum strain AN003 (GenBank accession ID. MW237703), were cultured on freshly prepared PDA plates for 4 days at 25 ± 2 °C. From the plates of both fungi, mycelial edges were cut (12 plugs, each with a diameter of 15 mm) and separately inoculated in Erlenmeyer flasks containing PDB (3 L for each fungus). The culture flasks were transferred to a shaker incubator (140 rpm and 25 ± 2 °C) for 3 days and then incubated statically for 14 days at 25 ± 2 °C. After incubation, the mycelia were separated from the culture broth using cotton gauze and then the culture broth was filtered through Whatman filter paper No.1 to obtain the mycelium-free filtrate. Fungal metabolites were extracted three times using EA solvent as described elsewhere with minor modifications [24]. In brief, the filtrate and EA were added (v/v) and agitated for 5–6 min in a separatory funnel, and then the upper (organic) layers were collected by separating the lower (aqueous) layers. The organic layers (EA extract) of both fungi were merged separately and condensed by evaporating the EA through a rotary evaporator at 38 °C. Finally, the EA extract of P. lanosum (EAE-PL) and the EA extract of P. radiatolobatum (EAE-PR) were collected, weighed, and kept at 4 °C for further experimentation.

2.3. Assessment of Total Phenolics and Flavonoid Content

The total phenolic content (TPC) and total flavonoid content (TFC) in the EAE-PL and the EAE-PR were analyzed according to a previous report [24] with slight modifications as described in the Supplementary Materials.

2.4. α-amylase and α-glucosidase Inhibition Assay

The α-amylase and α-glucosidase inhibitory activity of the EAE-PL and EAE-PR were evaluated according to a previously described protocol [8] as described in the Supplementary Materials.

2.5. Antioxidant Assays

2.5.1. ABTS+ and DPPH Radical Scavenging Assay

The ABTS+ and DPPH radical scavenging activity of the EAE-PL and EAE-PR were evaluated as described earlier [8] and in the Supplementary Materials.

2.5.2. Ferric-Reducing Power Assay

The ferric ion reducing potential of the EAE-PL and EAE-PR was assessed as reported previously [24,25]. In short, 500 µL of K3[Fe(CN)6] solution (30 mM) was mixed with 175 µL of PBS (0.6 M, pH 6.6), added to 100 µL of sample (EAE-PL and EAE-PR) separately, and then incubated for 20 min at 50 °C. Following incubation, 500 µL of freshly prepared trichloroacetic acid (10%) was added to the reaction mix and mixed well. Then, added 1500 µL of FeCl3 (0.1%) and mixed the solution. Finally, the absorbance was recorded at 700 nm. AA was taken as a positive control.

2.5.3. Determination of Peroxyl Radical Scavenging Capacity (PSC)

The peroxyl radical scavenging capacities of the EAE-PL, EAE-PR, and AA were assessed as reported previously [26] and compared. In short, 100 µL (1 mg/mL) of sample (EAE-PL, EAE-PR, and AA) was thoroughly mixed with 100 µL of DCFH-DA (2.48 mM) separately. The reaction was started by adding 50 µL of ABAP (200 mM) at 37 °C. The fluorescence of the reaction mix was read every 2 min at 538 nm after excitation at 485 nm for 40 min using a SpectraMax i3 microplate reader (Molecular Devices, Seoul, Republic of Korea).

2.6. Antibacterial Susceptibility Test

The antibacterial susceptibility of the EAE-PL and EAE-PR against Gram-positive (B. cereus, S. aureus, and L. monocytogenes) and Gram-negative (E. coli and S. enterica) pathogens was detected by a disc diffusion assay as per the Clinical Laboratory Standard Institute (CLSI) guidelines. Bacterial strains were cultured in NB medium and grown overnight at 37 ± 2 °C. The next day, 100 µL of bacterial suspension (1.5 × 104 CFU/mL) was spread onto fresh MHA plates using a sterile glass spreader. Then, 50 µL (500–1000 µg/mL) of test sample (EAE-PL and EAE-PR) was loaded onto sterile paper discs (6 mm diameter) and air dried. The sample-containing paper discs were placed on the bacterial plates and incubated at 37 ± 2 °C for 18 h. The ery (100 µg/mL) was taken as an positive control. PBS (50 µL) treatment was taken as an experimental negative control. Following incubation, the zone of growth inhibition was measured (in mm) around the discs using a Vernier scale.

Assessment of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The MIC and MBC of the EAE-PL and EAE-PR were determined on pathogenic strains (B. cereus, S. aureus, L. monocytogenes, E. coli, and S. enterica) using a microdilution assay. Each well of a 96-well flat bottom plate was filled with 100 µL of freshly prepared MHB. A bacterial suspension (1.5 × 104 CFU/mL) that had been grown overnight was added (10 µL) to the respective wells and treated (10 µL) with varying concentrations (0–1000 µg/mL) of test sample (EAE-PL and EAE-PR). The Ery (100 µg/mL) treated (10 µL) wells were taken as an experimental positive control and wells containing the bacterial suspension with PBS (10 µL) were considered to be a negative control. Then, the plates were incubated at 37 ± 2 °C, and the absorbance (at 600 nm) was recorded using a UV-vis microplate reader over time (0–24 h). Afterward, the MBC of the EAE-PL and EAE-PR was ascertained on the basis of turbidity and bacterial survival. From the wells without bacterial growth (no visible turbidity), 50 µL of suspension was streaked onto fresh MHA plates and maintained for 24 h at 37 ± 2 °C. Later, the bacterial colony growth was observed on the plates to determine the MBC value.

2.7. Cell Viability Analysis (MTT Assay)

The effect of EAE-PL, EAE-PR, and AA on the viability of HEK-293 cells was tested in an MTT assay as reported elsewhere [27]. Briefly, the cells were cultured in DMEM supplemented with FBS (10%) and PS (1%) antibiotics and incubated at 37 ± 1 °C in a humidified CO2 (5%) atmosphere. Exponentially growing cells (70–80% confluence) were seeded (104 cells/100 µL) in a 96-well plate (flat-bottom) and grown overnight under the above-mentioned conditions. The next day, the cells were separately treated (10 µL/well) with the serially diluted concentration (7.8–1000 µg/mL) of EAE-PL, EAE-PR, and AA and placed in the incubator for 12 h. Untreated cells were considered to be an experimental control. Following incubation, the MTT solution (5 mg/mL) was added (10 µL) to each well in the dark and incubated for 3 h. Later, the medium was removed from the wells, and 100 µL of DMSO was added to dissolve the Formazan crystals formed by the cells. The absorbance was recorded at a wavelength of 570 nm using a Microplate reader (SpectraMax® ABS Plus, Molecular Devices, San Jose, CA, USA) and the cell viability (%) was calculated.

Cell Viability Analysis (Fluorescent Staining Assay)

A fluorescent staining examination was used to investigate the physiological impact of the EAE-PL, EAE-PR, and AA on HEK-293 cells as stated elsewhere [28]. In brief, the cells were grown on a 24-well culture plate (4 × 104 cells/500 µL media/well) overnight at 37 ± 1 °C in a humidified CO2 (5%) incubator. The wells were treated (50 µL) with EAE-PL, EAE-PR, and AA at a concentration of 125 µg/mL and further incubated for 18 h. The nuclear variation, apoptotic stages, and necrotic damage were examined using AO/EB dual staining. Rh-123 staining was used to observe the alteration in the mitochondrial membrane potential, and DCFH-DA staining was used to analyze the ROS status. Images were captured on an Olympus CKX53 culture microscope (Tokyo, Japan).

2.8. Cytoprotective Activity against H2O2 Stress

The cytoprotective effect of the EAE-PL and EAE-PR against H2O2 induced stress was assessed in HEK-293 cells using an MTT assay. The cells were cultivated, seeded in a 96-well plate (flat-bottom), grown, treated, and experimented upon as previously mentioned (in the Cell Viability Analysis (MTT assay) section). Cells were treated (10 µL/well) with H2O2 (1.6 mM) and incubated for 30 min. Then, we added EAE-PL, EAE-PR, and AA (10 µL/well) at a serially diluted concentration (7.8–1000 µg/mL) and incubated the cells for 12 h. Finally, the cell viability (%) was calculated. The AA-containing wells were considered to be a positive control and only the H2O2-treated cells were considered to be a negative control. Later, the cytoprotective activity of the samples (125 µg/mL) against H2O2-stressed HEK-293 cells was substantiated by light and fluorescent staining examinations as described in the cell viability analysis (fluorescent staining assay) section. The cellular morphology was visualized using a light microscope, and fluorescent stains, namely PI and DCFH-DA, were used to distinguish dead cells and analyze the ROS status, respectively.

2.9. Metabolite Profiling by UHPLC-Q-TOF-MS/MS

Bioactive compounds of the EAE-PL and EAE-PR were analyzed through an ultra-high-performance liquid chromatograph equipped with a quadrupole time-of-flight mass spectrometer (UHPLC-Q-TOF-MS/MS) using a SCIEX ExionLCTM AD series-equipped X500R Q-TOF system (Framingham, MA, USA) [29]. The samples (EAE-PL and EAE-PR) were prepared at a concentration of 1000 μg/mL by dissolution in EtOH (70%) and then filtered using syringe filters (0.2 µm). The samples (10 µL) were injected into the autosampler (100 × 3 mm, AccucoreTM C-18 column) and eluted through binary mobile phases A (water and 0.1% formic acid) and B (methanol) at a flow rate of 0.4 mL/min in a linear gradient program (25 min). The MS analysis was performed in both electrospray ionization modes (ESI+ and ESI-). In the (+) ionization mode, the voltage (+40 V) and capillary temperature (320 °C) were set with a spray voltage of 3.6 kV. In the (−) ionization mode, the voltage, capillary temperature, and spray voltage were set to −40 V, 320 °C, and 2.7 kV, respectively. Spectral libraries such as Metlin (XCMS Online), Pubchem, and ChemSpider were utilized for the identification of compounds.

2.10. Molecular Docking Analysis

The possible mechanism behind the bioactivities of the tentatively identified fungal compounds was assessed through an in silico molecular docking study. Briefly, to prepare the structures of the selected compounds (ligands), the colonial smiles were retrieved from NIH PubChem. Then, using UCSF chimera software (1.16), the structure of the ligands was designed, the energy was minimized, and the structures were saved as mol files. The crystal structure (protein data bank (PDB) files) of target proteins, such as α-amylase (PDB: 1OSE), α-glucosidase (PDB: 5NN8), NADPH-oxidase (PDB: 2CDU), and D-alanine D-alanine ligase (PDB: 2PVP), were downloaded from the RCSB PDB database. The molecular interactions among the ligands (mol files) and target proteins (PDB files) were carried out in the ArgusLab program (V.4.0.1). The water molecules and miscellaneous residues were removed from the target proteins and the binding packet was set before the docking run. Docking results were visualized using the BIOVIA Discovery Studio Visualizer (V.21.1.0.20298) tool. Acarbose (C25H43NO18), ascorbic acid (C12H16O13), and erythronolide A (C21H38O8) were used as positive controls.

2.11. Statistical Analysis

Each experiment was run in triplicate, and the results are shown as the mean ± standard deviation. The samples’ significance was calculated using the one-way analysis of variance (ANOVA; p < 0.05). The ‘prcomp’ program was used to perform Principle Component Analysis (PCA) to explain the variance in the data set. Using Ward’s linkage and Pearson’s correlation program, hierarchical cluster analysis was performed to produce heatmaps. The analysis of the metabolite pathway was performed based on the p-value (0~1) using the Kyoto Encyclopedia of Genes and Genomes (KEGG) compound database annotation in the OmicStudio web-tool.

3. Results and Discussion

Endophytic fungi are among the most important components in the plant–microbe interaction ecosystem and are also rich sources of natural products with pharmacological properties [20]. Secondary metabolites are of great importance due to their anticancer, antioxidant, and antibacterial activities. From an endophytic fungus fermentation broth, secondary metabolites with different compounds, contents, and quantities can be isolated using various solvents. The polar and medium-polar solvents are more effective at extracting low- and high-molecular-weight polyphenols compared with non-polar solvents [10]. However, EA is reported to be the most effective solvent for extracting mid-polar secondary metabolites with a higher yield and polyphenol content [8,11,20].

3.1. Total Yield and Polyphenolics Quantification

An analysis of the total yield, total phenolic content, and total flavonoid content of the EAE-PL and EAE-PR is presented in Table 1. The extract yield was noted to be 0.41 ± 0.08% and 0.63 ± 0.05% for the EAE-PL and EAE-PR, respectively. Polyphenols contain hydroxyl groups with a hydrogen-donating capacity and possibly contribute to antioxidation, free radical scavenging, and stabilizing lipid oxidation [30,31]. The TPC of the EAE-PL was determined to be 17.89 ± 1.63 mg of gallic acid equivalents, dry weight (GAE/g DW) and the TPC of the EAE-PR was noted to be 119.87 ± 3.74 mg of GAE/g DW (Table 1). The TFC of the EAE-PL and EAE-PR was determined to be 3.31 ± 0.96 mg of quercetin equivalents, dry weight (QE/g DW) and 16.26 ± 1.95 mg of QE/g DW, respectively (Table 1). It is evident that flavonoids are one of the major compounds in the overall polyphenol composition of natural extracts and are associated with antioxidant, antibacterial, anti-inflammatory, and immunoregulatory activities [32].

3.2. α-amylase and α-glucosidase Inhibition Activities

α-amylase and α-glucosidase are hydrolytic enzymes known to catalyze the hydrolysis of starch and disaccharides, respectively. In humans, α-amylases hydrolyze starch into maltodextrin and glucose, while α-glucosidases hydrolyze disaccharides (sucrose and maltose) into monosaccharides (fructose and glucose). Therefore, inhibiting the activity of α-amylase and α-glucosidase controls the rise in blood sugar levels and prevents postprandial hyperglycemia and type-2 diabetes [10]. However, fungal compounds such as alkaloids, flavonoids, fatty acids, phenolic acids, and triterpenes have been reported to be potential α-amylase and α-glucosidase inhibitors [7]. This study evaluated the α-amylase and α-glucosidase inhibitory activities of the EAE-PL and EAE-PR compared to AC as presented in Figure S1. The inhibition (%) activities of the tested samples were found to be proportional to the tested concentration for both α-amylase (Figure S1a) and α-glucosidase (Figure S1b) enzymes. Yet, the half-maximal inhibitory concentration (IC50) of the EAE-PL for α-amylase and α-glucosidase inhibition could not be determined up to the highest tested concentration (1000 µg/mL) (Table 2). However, the EAE-PR inhibited the activity of α-amylase and α-glucosidase with an IC50 value of 362.5 and 525 µg/mL, respectively. Meanwhile, AC exhibited a lower IC50 value for α-amylase (37.5 µg/mL) and α-glucosidase (87.5 µg/mL) inhibition (Table 2). An earlier study also reported the α-glucosidase inhibitory activity of the EA of endophytic P. citrinum to have an IC50 value of 2800 µg/mL [33].

3.3. Antioxidant Activities

Antioxidants help to maintain regular metabolism in the mammalian system by preventing oxidative stress and associated ailments. In particular, antioxidants act as the substrate for the incomplete oxygen reduction of ROS production in mitochondria and prevent oxidative damage to cells [24,34]. However, a single antioxidant experiment remains insufficient to comprehensively anticipate the antioxidant efficacy of natural extracts. So, the antioxidant potentials of the EAE-PL and EAE-PR were evaluated through ABTS+ and DPPH radical scavenging, ferric-reducing power, and PSC assays as can be seen in Figures S2–S4 and Table 2.
The DPPH and ABTS+ assays are traditional, rapid, and renowned methods for determining antioxidant activity. The antioxidants function as electron donors to neutralize the DPPH free radicals and scavenge the ABTS+ radicals by inhibiting the activity of potassium persulphate [22]. Experimental findings indicate the concentration-dependent ABTS+ and DPPH radical scavenging activity of the tested samples (EAE-PL, EAE-PR, and AA) (Figure S2a,b). The IC50 of the EAE-PL and EAE-PR for ABTS+ radical scavenging was determined to be 59.5 and 37.5 µg/mL, respectively, compared with AA (49.25 µg/mL) (Table 2). However, for the EAE-PL, the IC50 value for DPPH radical scavenging could not be determined up to 1000 µg/mL, yet the EAE-PR exhibited an IC50 value of 187.5 µg/mL, compared with AA (241.6 µg/mL) (Table 2). It should be noted that ABTS and DPPH radicals are structurally different, and some organic compounds, such as dihydrochalcones and flavanones, do not react with DPPH radicals, unlike ABTS radicals [35]. This could be the possible reason for the significant differences in the ABTS+ and DPPH radical scavenging activities (IC50) of the EAE-PL and EAE-PR.
The reducing powers of the antioxidants are attributed to their electron donation capability and free radical quenching capacity [36]. The ferric-reducing potential of the tested samples (EAE-PL, EAE-PR, and AA) was also found to be concentration-dependent (Figure S3) with an IC50 value of 733.3, 175.0, and 326.5 µg/mL for the EAE-PL, EAE-PR, and AA, respectively (Table 2). Similarly, a previous study reported the ferric reducing potential of the EAE of endophytic Paraconiothyrium brasiliense to have an IC50 value of 358 ± 1.56 µg/mL [24]. It is believed that, in organic extracts, phenolic acids that contain aromatic rings with carboxyl and hydroxyl residues hold ROS-neutralizing and transition-metal-reducing powers. However, nonmethylated phenolic acid derivatives are reported to have higher ferric-reducing powers compared with methylated ones [37].
The PSC assay is a simple, rapid, and sensitive technique by which to evaluate the ability of organic extracts to scavenge peroxyl radicals and is considered superior to DPPH, ABTS, and FRAP assays because it represents naturally occurring ROS and physiological parameters (pH and temperature) of mammalian systems [26]. The peroxyl radical scavenging activity of the tested samples (EAE-PL, EAE-PR, and AA) was observed to be time-dependent (up to 40 min) (Figure S4a). The EAE-PR and AA exhibited over 90% of the PSC when observed at the 40th minute (Figure S4b). The PSC (IC50) of the EAE-PR (532.36 µg/mL) was found to be nearly equal to that of the AA (521.86 µg/mL) and substantially higher than that of the EAE-PL (>1000 µg/mL) (Table 2). The natural extracts contain a mixture of substances, carbohydrates, and peptide contents that might affect their antioxidant activities via a potential synergistic action compared with individual substances [35]. Additionally, our results suggest a significant correlation between total polyphenolic content and antioxidant potency and corroborate previous findings [8,10,11,20,31].

3.4. Antibacterial Activity

The disc diffusion assay is a qualitative approach to defining the susceptibility of bacterial strains to an antibacterial agent. In the past, natural products played a significant role in the discovery and development of antibacterial agents. The rapid growth of resistant bacterial strains has required a re-evaluation of these systems as a means of identifying novel chemical skeletons with antibacterial activity for the development of new drugs [38]. The bacterial susceptibility to the EAE-PL and EAE-PL was measured as the zone of inhibition (ZoI) (Figure 1 and Table 3). All the tested strains exhibited a ZoI towards the highest tested concentration (1000 µg/mL) of the EAE-PL and EAE-PR (Figure 1a–e). Although the treatment with 500 µg/mL of EAE-PL showed a ZoI against B. cereus (9 ± 0.5 mm), a significant ZoI could not be detected against S. aureus (0 mm), L. monocytogenes (0 mm), E. coli (6.5 ± 0.2 mm), or S. enterica (0 mm). However, the ZoI ranged from 8 ± 0.3 to 11.5 ± 1 mm against the tested pathogens for the EAE-PR (500 µg/mL) treatment. However, Ery (100 µg/mL) exhibited a ZoI range (21 ± 0.8–22 ± 1.5 mm) against the tested pathogens (Table 3). Phenolic compounds from natural sources possess a wide range of structural characteristics, including the presence/absence, substitution position, and number of hydroxyl groups as well as the length of saturated side chains, all of which possibly contribute to their antibacterial action [39]. The findings of the disc diffusion assay suggest that EAE-PL and EAE-PR have bacterial-strain-specific and concentration-dependent (500–1000 µg/mL) antibacterial activity.
The microtiter assay is a quantitative approach to defining the MIC and MBC of bacterial strains to an antimicrobial agent. The MIC and MBC of the EAE-PL and EAE-PR were determined as can be seen in Figures S5 and S6 and Table 4. The MIC (µg/mL) of the EAE-PL was determined for B.cereus, S. aureus, L. monocytogenes, E. coli, and S. enterica to be 62.5, 500, 500, 125, and 250, respectively. The EAE-PR exhibited comparatively lower MIC values, such as 31.25 µg/mL (B. cereus), 125 µg/mL (S. aureus), 31.25 µg/mL (L. monocytogenes), 62.5 µg/mL (E. coli), and 62.5 µg/mL (S. enterica) (Figures S5 and S6 and Table 4). Similarly, in a recent report, the EA extract of the endophytic P. oxalicum exhibited an MIC range of 500–2000 µg/mL against E. coli, Pseudomonas aeruginosa, S. aureus, and B. subtilis [20]. Furthermore, the EAE-PL exhibited higher MBC values compared with the EAE-PR. For the EAE-PL, only B. cereus and E. coli exhibited an MBC of 500 µg/mL, whereas the MBC against S. aureus, L. monocytogenes, and S. enterica could not be determined below 1000 µg/mL. Moreover, the MBC of the EAE-PR was determined to be 125 µg/mL, 500 µg/mL, 125 µg/mL, 250 µg/mL, and 250 µg/mL for B. cereus, S. aureus, L. monocytogenes, E. coli, and S. enterica, respectively (Figures S5 and S6 and Table 4). Inhibition of the apparent growth (colony) of bacterial cells may be due to a disruption of cell membrane integrity or suppression of DNA and/or protein synthesis resulting in cell death [21,22]. It should be noted that the genetic makeup and phenotypic traits of bacterial cells determine their response to different antimicrobial agents [40]. Moreover, the difference in chemical composition could also be the reason for the different antibacterial effects of the EAE-PL and EAE-PR against the tested bacterial cells (Figure 1, Figures S5 and S6 and Table 3 and Table 4).

3.5. Cell Viability Analysis

Endophytic fungi are known to produce strong cytotoxic metabolites that raise concerns about the therapeutic application of their extracts. Hence, the effect of the EAE-PL, EAE-PR, and AA on the viability of HEK-293 cells was tested and is presented in Figure 2. The outcome of the MTT assay indicated a trivial reduction in the viability of HEK-293 cells at the tested concentrations (250–1000 µg/mL) of samples (EAE-PL, EAE-PR, and AA) compared with untreated (control) cells. Although the treatment with AA (1000 µg/mL) resulted in a decrease (~30%) in the viability of cells, the treatment with a lower dose of AA (15.6 µg/mL) and EAE-PL (62.5 µg/mL) increased the viability (>100%) compared with control cells (Figure 2a). The non-toxicity of the EAE-PL, EAE-PR, and AA towards HEK-293 cells could be accredited to their antioxidant behavior. Additionally, natural extracts have the characteristic of selective toxicity towards different cell types. For instance, the EAE of endophytic Paraconiothyrium brasiliense is highly toxic to prostate cancer cells (PC3) but non-toxic to HEK-293 cells [24].
Furthermore, the findings of the MTT assay on HEK-293 cells were corroborated by the fluorescent staining assay as can be seen in Figure 2b–d. In the AO/EB dual staining assay, the treatment with EAE-PL, EAE-PR, and AA did not show a difference in cellular morphology compared to the control cells. However, the EAE-PR-treated cells demonstrated an insignificant number of apoptotic cells (orange fluorescence) (Figure 2b). However, the Rh-123 stain did not evidence a noteworthy mitochondrial membrane potential loss in the EAE-PL, EAE-PR, and AA-treated cells compared to the control cells (Figure 2c). In the DCFH-DA staining results, the EAE-PR-treated cells exhibited an inconsequential yet higher ROS level (intense green fluorescence) compared with the other treatments (EAE-PL and AA) and the control cells (Figure 2d).

3.6. Cytoprotective Effect against H2O2 Stress

It is evident that natural extracts can exhibit different antioxidant capacities in distinct chemical and biological systems (in vitro, ex vivo, and in vivo) [41,42]. In that respect, cell-based assays offer a complex and more physiologically and biologically realistic system as the cellular environment can imitate disease states, sustain a signaling cascade, and simulate the tested compounds’ response. Therefore, the cytoprotective activity of the EAE-PL, EAE-PR, and AA was tested in HEK-293 cells subjected to H2O2 stress (Figure 3). The H2O2 treatment of HEK-293 cells showed cell viability (~30%) compared with control cells (100%). Dose-dependent protection was observed against the treated (7.8–1000 µg/mL) samples and the cell viability was increased to 43%, 59%, and 55% by 125 µg/mL of EAE-PL, EAE-PR, and AA, respectively, indicating 13%, 29%, and 25% recovery from H2O2-induced cell damage (Figure 3a). However, at higher concentrations (125–1000 µg/mL), the EAE-PR exhibited a greater cytoprotective effect compared with AA. This is also in line with previous studies suggesting that the combination of AA and H2O2 might also act as a pro-oxidant [43,44].
In addition, the cytoprotective activity of the EAE-PL, EAE-PR, and AA was substantiated through light microscopy and PI and DCFH-DA staining assays (Figure 3b–d). During light microscopy, the control cells appeared in large numbers with an organized cellular morphology, such as a complete cell structure, a dense cytoplasm, and regular arrangement and attachment. However, H2O2-treated cells were found in reduced numbers and with an atrophied cell morphology. The EAE-PL-treated cells were also observed to have a changed cell structure and severe damage. However, the EAE-PR and AA-treated cells were found to have an improved cell density and recovered from the abnormal cell structure (Figure 3b). Using the nucleic acid stain PI, dead cells can be distinguished (red fluorescence) in a population of cells [10]. Compared with the control cells, severe cell death (a higher number of cells with a red fluorescence) was observed in the H2O2 treatment group. Moreover, EAE-PR-treated cells had a higher number of viable HEK-293 cells (a smaller number of cells with a red fluorescence) compared with the H2O2, EAE-PL, and AA treatment groups (Figure 3c). Moreover, the DCFH-DA staining results indicate a high ROS level in the H2O2 treatment group compared with control cells. A significant reduction in ROS status was observed in EAE-PR-treated cells compared with other samples (EAE-PL and AA), indicating a reduction in ROS-mediated toxicity (Figure 3d). However, a previous study also reported similar findings, where organic extracts of Xylaria nigripes significantly protected PC12 (rat pheochromocytoma) cells from H2O2-mediated cell damage by preventing lactate dehydrogenase release, reducing DNA damage, restoring the mitochondrial membrane potential, and preventing aberrant apoptosis by upregulating Bcl-2 and downregulating Bax and caspase 3 [45].

3.7. Metabolite Profiling by UHPLC-Q-TOF-MS/MS

The UHPLC-Q-TOF-MS/MS technique is regarded as one of the most sensitive strategies for the accurate detection and quantification of a wide range of polar compounds in secondary metabolites, including phenolics and terpenoids. Hence, the potential compounds present in EAE-PL and EAE-PR were analyzed using UHPLC-Q-TOF-MS/MS and tentatively identified (Table 5 and Table 6). A total of 20 compounds were tentatively identified in the EAE-PL sample group as shown in Table 5. The EAE-PR sample group exhibited the presence of a total of 26 tentatively identified compounds (Table 6). However, sorbic acid, phenylacetic acid, and ferulic acid were identified in both the EAE-PL and EAE-PR sample groups. A recent LC-MS characterization documented the presence of sorbic acid in the EAE of endophytic Chaetomium subaffine and described it as a potent antibacterial compound [46]. Phenylacetic acid and 3-indoleacetic acid, classified as plant hormones (auxins), could be produced by fungi as antimicrobial and antioxidant agents to assist with biological control and help plant growth [47,48]. In some recent studies, ferulic acid was reported to be one of the major phenolics in the extract of endophytic P. roqueforti and P. oxalicum [20,49]. In addition, vanillin, scopoletin, and sinapic acid were identified as major constituents of EAE-PR (Table 6). Moreover, the antioxidant and cytotoxic EAE of P. citrinum exhibited the presence of vanillin and coumaric acid in a UHPLC analysis [50]. It has been reported that the biosynthesis of secondary metabolites, such as scopoletin and isofraxidin, occurs via the shikimic acid pathway within the endophytic system [51]. However, Brader et al. reported that isofraxidin is also involved in the biosynthesis of scopoletin, aesculetin, and fraxetin, which were also identified in the EAE-PR (Table 6) [52]. In addition, sinapic acid has been identified to be a major phenolic acid in the EAE of marine-derived P. brevicompactum and is reported to have antioxidant and cytotoxic activities [53]. Similarly, maculosin has been reported to be an antimicrobial agent and is isolated from the EAE of endophytic P. chrysogenum [54]. Overall, the UHPLC-Q-TOF-MS/MS findings indicate a higher abundance of compounds in the EAE-PR sample group compared with the EAE-PL samples (Table 5 and Table 6). Perhaps this could be the reason for the higher bioactivities (tested in this study) of the EAE-PR compared with the EAE-PL.
Statistical measures (Unsupervised) such as PCA are utilized to minimize the number of variables in multivariate data while keeping the majority of the variation [55]. The significant differences between the EAE-PL and EAE-PR sample datasets (three groups from each sample set) were confirmed by multivariate statistical analysis (Figure 4). Therefore, the PCA analysis was utilized to examine the discriminative metabolites and identify metabolic differences between the samples (EAE-PL and EAE-PR). The PCA score plot indicated two sample clusters (EAE-PL and EAE-PR), reflecting the differentiation between the two groups. The first two principal components (PCs) exhibited 100% of the total variance (PC1, 100%; PC2, 0%), indicating the clear separation of both the samples and the metabolites and suggesting a high degree of diversity among the EAE-PL and EAE-PR samples (Figure 4a). Furthermore, the statistical variation in the dataset of the sample groups was established by the heatmap generated using the cluster separation results. The heatmap demonstrated the qualitative composition and the relative abundance of the compounds tentatively identified in the EAE-PL and EAE-PR (Figure 4b). Three groups in the heatmap indicate the replicate value of each sample set (EAE-PL and EAE-PR). The analyzed compounds can be clustered using a heatmap analysis based on concentrations, where the color pattern from red to blue (in this study) depicts concentrations in descending order [29].
The KEGG database was used to analyze the dominant pathways correlated with the tentatively identified metabolites (EAE-PL and EAE-PR) and the metabolism of differentially regulated metabolites as presented in Figure 5. However, quite different dominant pathways were observed in P. lanosum and P. radiatolobatum-associated metabolites (Figure 5a,b). The results indicate that all metabolites (tentatively identified in the EAE-PL and EAE-PR) followed three major pathways, including biosynthesis of secondary metabolites, phenylalanine metabolism, and biosynthesis of phenylpropanoids. It is evident that these pathways are positively correlated with the generation of phenolic acids (ferulic acid, p-coumaric acid, and sinapic acid) from a phenylalanine precursor [56]. Moreover, the pathway associated with the biosynthesis of plant hormones (Figure 5b) could be positively correlated with the synthesis of phenylacetic acid and 3-indoleacetic acid (Table 6).

3.8. Molecular Docking Analysis

Along with biological properties, the investigation of the physicochemical properties of candidate compounds is crucial for the development of therapeutic agents. So, the tentatively identified compounds of EAE-PL and EAE-PR were examined in order to predict their pharmacokinetic, physicochemical, drug-likeness, and related parameters according to Lipinski’s rule of five [10]. However, the compounds identified in the EAE-PL and EAE-PR did not violate any of Lipinski’s five rules (Tables S1 and S2). In this study, since the EAE-PR demonstrated substantially higher in vitro bioactivities than the EAE-PL, the compounds tentatively identified in the EAE-PR were selected for in silico molecular docking studies. In molecular docking experiments, the hypothesized antidiabetic, antioxidant, and antibacterial activities of mycocompounds and their probable mode of action were deduced on the respective target proteins (α-amylase and α-glucosidase, NADPH-oxidase, and D-alanine D-alanine ligase) via their molecular interaction at the atomic level. α-amylase and α-glucosidase inhibitory compounds from natural sources have shown potential responses in hyperglycemia management and have attracted researchers from around the world. The NADPH oxidases utilize the Nox catalytic subunit to catalyze the transfer of electrons from NADPH to molecular O2 to generate ROS such as superoxide or H2O2. In bacteria, D-alanine D-alanine ligases are essential ATP-dependent enzymes participating in cell wall (peptidoglycan) biosynthesis. Therefore, these enzymes (NADPH oxidase and D-alanine D-alanine ligase) are considered prominent targets for antioxidant and antibiotic development.
The molecular docking study was precisely focused on the free binding energy, H-bonding, carbon–hydrogen (C-H) bonding, and Van der Waals interactions (VDIs). The H-bonding and VDIs are associated with the binding interactions, whereas the C-H bonding and Pi–sigma interactions are associated with the stability of ligands (selected compounds) and the receptor-docked complex [57]. The scores of docking binding energies among the binding sites of target (α-amylase and α-glucosidase, NADPH-oxidase, and D-alanine D-alanine ligase) proteins are presented in Table 7. In addition, the H-bonding, C-H bonding, and VDIs with amino acids involved at the binding sites of α-amylase and α-glucosidase (Table S3) and NADPH oxidase and D-alanine D-alanine ligase (Table S4) against the ligands during the docking run are also summarized. Among the selected ligands, thiophene A exhibited the highest binding energy (kcal/mol) with the target α-amylase (−9.75), α-glucosidase (−11.74), NADPH oxidase (−10.96), and D-alanine D-alanine ligase (−12.06) proteins (Table 7). The docking simulation of thiophene A with the crystal structure of α-amylase and α-glucosidase during the in silico molecular interaction is shown in Figure 6a–d. Interaction of thiophene A with α-amylase was not related to H-bonding and C-H bonding, but was associated with 11 VDIs (TRP58, TRP59, GLU60, GLN63, GLY104, SER105, GLY106, GLY164, ARG195, ASP197, and ASP300) (Figure 6b and Table S3). With α-glucosidase, thiophene A interacted through three VDIs (THR700, ALA704, and GLN776) and other non-covalent interactions (Figure 6d and Table S3). Furthermore, Figure 7a–d depict the in silico molecular docking simulation of thiophene A with the crystal structure of NADPH oxidase and D-alanine D-alanine ligase. However, the docking of thiophene A with NADPH oxidase and D-alanine D-alanine ligase indicated six VDIs (HIS10, PHE14, GLY59, ARG308, PRO816, and ARG882) and five VDIs (ASN129, GLU203, GLU451, ASP590, and SER589), respectively (Figure 7b,d and Table S4).
The docking simulation of hematommic acid with α-amylase and limonene with α-glucosidase can be seen in Figure S7a–d. Moreover, the docking simulation of limonene with NADPH oxidase and D-alanine D-alanine ligase is shown in Figure S8a–d. Similarly, previous studies also predicted the enzyme inhibitory activity (α-glucosidase inhibition) of the compounds present in the EAE of endophytic Diaporthe sp. and the bioactivities (antioxidant and antibacterial) of the compounds produced by endophytic P. pinophilum using molecular docking studies [9,22]. The molecular docking observations (made in this study) suggested that compounds with noteworthy α-amylase and α-glucosidase inhibition, antioxidant, and antibacterial potential are present in the EAE-PR.

4. Conclusions

Novel therapeutic agents derived from natural sources could help us to address persistent/future concerns related to NCDs, bacterial infections, and antibacterial resistance. This study examined and compared the antidiabetic, antioxidant, antibacterial, and cytotoxic activities of the ethyl acetate extracts of two endophytic Penicillium sp. (EAE-PL and EAE-PR). Compared with EAE-PL, the EAE-PR showed higher α-amylase and α-glucosidase inhibition, free radical scavenging, antibacterial activity, and protective effects against H2O2 in HEK-293 cells. The UHPLC-Q-TOF-MS/MS studies manifested the presence of bioactive compounds in the EAE-PR. Furthermore, in silico molecular docking interactions of bioactive compounds, namely thiophene A, limonene, and phenylacetic acid, against α-amylase, α-glucosidase, NADPH oxidase, and D-alanine D-alanine ligase indicate the possible reason for the antidiabetic, antioxidant, and antibacterial activities of the EAE-PR. Yet, further investigations are needed to fractionate and characterize specific bioactive compounds for the development, validation, and design of potent therapeutic drugs.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antiox12020248/s1, Figure S1: Analysis of the α-amylase inhibition and α-glucosidase inhibitory effect (b) of EAE-PL and EAE-PR; Figure S2: ABTS radical scavenging activity and DPPH radical scavenging activity of EAE-PL and EAE-PR; Figure S3: Ferric-reducing antioxidant power of EAE-PL and EAE-PR; Figure S4: The peroxyl radical scavenging activity (PSC) of EAE-PL and EAE-PR; Figure S5: Determination of the minimum inhibitory concentration (MIC) of EAE-PL and EAE-PR against Gram-positive pathogens; Figure S6: Determination of the minimum inhibitory concentration (MIC) of EAE-PL and EAE-PR against Gram-negative pathogens; Table S1: The analysis of pharmacokinetic properties of the tentatively identified compounds from EAE-PL using Lipinski’s rule of five; Table S2: The analysis of pharmacokinetic properties of the tentatively identified compounds from EAE-PR using Lipinski’s rule of five; Figure S7: The structural overlay and 3D and 2D docking simulation of hematommic acid with the crystal structure of α-amylase and limonene with α-glucosidase; Figure S8: The structural overlay and 3D and 2D docking simulation of limonene with the crystal structure of NADPH oxidase and D-alanine D-alanine ligase; Table S3: Summary of the hydrogen bonding and Van der Waals interactions with involved amino acids within the binding pockets of α-amylase (PDB: 1OSE) and α-glucosidase (PDB: 5NN8) against the active compounds of EAE-PR; Table S4: Summary of the hydrogen bonding and Van der Waals interactions with involved amino acids within the binding pockets of NADPH oxidase (PDB: 2CDU) and D-alanine D-alanine ligase (PDB: 2PVP) against the active compounds of EAE-PR.

Author Contributions

Conceptualization, data curation, investigation, methodology, writing—original draft, writing—review and editing, K.V.N.; conceptualization, data curation, investigation, methodology, writing—review and editing, K.S.; conceptualization, data curation, investigation, methodology, writing—review and editing, A.S.; funding acquisition, project administration, resources, software, supervision, validation, M.-H.W. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research Foundation of Korea (2021R1I1A1A01057742; 2022R1I1A1A01067464; NRF-2022R1A2C2091029).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this article are available on request.

Conflicts of Interest

The authors declare that they do not have any conflict of interest.

References

  1. World Health Organization. Noncommunicable Diseases Progress Monitor 2022; World Health Organization: Geneva, Switzerland, 2022. [Google Scholar]
  2. Yadav, M.; Yadav, A.; Yadav, J.P. In vitro antioxidant activity and total phenolic content of endophytic fungi isolated from Eugenia jambolana Lam. Asian Pac. J. Trop. Med. 2014, 7, S256–S261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Anthony, K.P.; Saleh, M.A. Free radical scavenging and antioxidant activities of silymarin components. Antioxidants 2013, 2, 398–407. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Cheeseman, K.H.; Slater, T.F. An introduction to free radical biochemistry. Br. Med. Bull. 1993, 49, 481–493. [Google Scholar] [CrossRef]
  5. Ayoka, T.O.; Ezema, B.O.; Eze, C.N.; Nnadi, C.O. Antioxidants for the Prevention and Treatment of Non-communicable Diseases. J. Explor. Res. Pharmacol. 2022, 7, 178–188. [Google Scholar] [CrossRef]
  6. Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.N.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109119. [Google Scholar] [CrossRef] [PubMed]
  7. Papoutsis, K.; Zhang, J.; Bowyer, M.C.; Brunton, N.; Gibney, E.R.; Lyng, J. Fruit, vegetables, and mushrooms for the preparation of extracts with α-amylase and α-glucosidase inhibition properties: A review. Food Chem. 2021, 338, 128119. [Google Scholar] [CrossRef]
  8. Sathiyaseelan, A.; Park, S.; Saravanakumar, K.; Mariadoss, A.V.A.; Wang, M.-H. Evaluation of phytochemicals, antioxidants, and antidiabetic efficacy of various solvent fractions of Gynura procumbens (Lour.) Merr. Process Biochem. 2021, 111, 51–62. [Google Scholar] [CrossRef]
  9. Mugaranja, K.P.; Kulal, A. Inhibition of alpha-glucosidase enzyme and antioxidant activity of the metabolites purified from an endophytic fungus of Simarouba glauca DC. S. Afr. J. Bot. 2022, 149, 134–144. [Google Scholar] [CrossRef]
  10. Saravanakumar, K.; Park, S.; Sathiyaseelan, A.; Kim, K.-N.; Cho, S.-H.; Mariadoss, A.V.A.; Wang, M.-H. Metabolite profiling of methanolic extract of Gardenia jaminoides by LC-MS/MS and GC-MS and its anti-diabetic, and anti-oxidant activities. Pharmaceuticals 2021, 14, 102. [Google Scholar] [CrossRef]
  11. Mariadoss, A.V.A.; Park, S.; Saravanakumar, K.; Sathiyaseelan, A.; Wang, M.-H. Ethyl acetate fraction of Helianthus tuberosus L. induces anti-diabetic, and wound-healing activities in insulin-resistant human liver cancer and mouse fibroblast cells. Antioxidants 2021, 10, 99. [Google Scholar] [CrossRef]
  12. Rai, N.; Gupta, P.; Keshri, P.K.; Verma, A.; Mishra, P.; Kumar, D.; Kumar, A.; Singh, S.K.; Gautam, V. Fungal Endophytes: An Accessible Source of Bioactive Compounds with Potential Anticancer Activity. Appl. Biochem. Biotechnol. 2022, 194, 3296–3319. [Google Scholar] [CrossRef] [PubMed]
  13. Naveen, K.V.; Sathiyaseelan, A.; Mariadoss, A.V.A.; Xiaowen, H.; Saravanakumar, K.; Wang, M.-H. Fabrication of mycogenic silver nanoparticles using endophytic fungal extract and their characterization, antibacterial and cytotoxic activities. Inorg. Chem. Commun. 2021, 128, 108575. [Google Scholar] [CrossRef]
  14. Liu, S.; Su, M.; Song, S.-J.; Jung, J.H. Marine-Derived Penicillium Species as Producers of Cytotoxic Metabolites. Mar. Drugs 2017, 15, 329. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Toghueo, R.M.K.; Boyom, F.F. Endophytic Penicillium species and their agricultural, biotechnological, and pharmaceutical applications. 3 Biotech 2020, 10, 107. [Google Scholar] [CrossRef] [PubMed]
  16. Ikuta, K.S.; Swetschinski, L.R.; Robles Aguilar, G.; Sharara, F.; Mestrovic, T.; Gray, A.P.; Davis Weaver, N.; Wool, E.E.; Han, C.; Gershberg Hayoon, A.; et al. Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022, 400, 2221–2248. [Google Scholar] [CrossRef]
  17. Oliver, S.P. Foodborne Pathogens and Disease Special Issue on the National and International PulseNet Network. Foodborne Pathog. Dis. 2019, 16, 439–440. [Google Scholar] [CrossRef]
  18. Scallan, E.; Hoekstra, R.M.; Angulo, F.J.; Tauxe, R.V.; Widdowson, M.A.; Roy, S.L.; Jones, J.L.; Griffin, P.M. Foodborne illness acquired in the United States—Major pathogens. Emerg. Infect. Dis. 2011, 17, 7–15. [Google Scholar] [CrossRef]
  19. Cueva, C.; Moreno-Arribas, M.V.; Martín-Álvarez, P.J.; Bills, G.; Vicente, M.F.; Basilio, A.; Rivas, C.L.; Requena, T.; Rodríguez, J.M.; Bartolomé, B. Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria. Res. Microbiol. 2010, 161, 372–382. [Google Scholar] [CrossRef]
  20. Tang, Z.; Qin, Y.; Chen, W.; Zhao, Z.; Lin, W.; Xiao, Y.; Chen, H.; Liu, Y.; Chen, H.; Bu, T.; et al. Diversity, chemical constituents, and biological activities of endophytic fungi isolated from Ligusticum chuanxiong Hort. Front. Microbiol. 2021, 12, 771000. [Google Scholar] [CrossRef]
  21. George, T.K.; Joy, A.; Divya, K.; Jisha, M.S. In vitro and in silico docking studies of antibacterial compounds derived from endophytic Penicillium setosum. Microb. Pathog. 2019, 131, 87–97. [Google Scholar] [CrossRef]
  22. Nischitha, R.; Shivanna, M.B. Metabolite fingerprinting, in vitro antimicrobial and antioxidant activities and in-silico docking in Alloteropsis cimicina and its endophytic fungus Penicillium pinophilum. Mol. Biol. Rep. 2021, 48, 4021–4037. [Google Scholar] [CrossRef] [PubMed]
  23. Gunarto, L.; Adachi, K.; Senboku, T. Isolation and selection of indigenous Azospirillum spp. from a subtropical island, and effect of inoculation on growth of lowland rice under several levels of N application. Biol. Fertil. Soils 1999, 28, 129–135. [Google Scholar] [CrossRef]
  24. Sathiyaseelan, A.; Saravanakumar, K.; Mariadoss, A.V.A.; Kim, K.M.; Wang, M.-H. Antibacterial activity of ethyl acetate extract of endophytic fungus (Paraconiothyrium brasiliense) through targeting dihydropteroate synthase (DHPS). Process Biochem. 2021, 111, 27–35. [Google Scholar] [CrossRef]
  25. Gao, X.; Xue, Z.; Ma, Q.; Guo, Q.; Xing, L.; Santhanam, R.K.; Zhang, M.; Chen, H. Antioxidant and antihypertensive effects of garlic protein and its hydrolysates and the related mechanism. J. Food Biochem. 2020, 44, e13126. [Google Scholar] [CrossRef] [PubMed]
  26. Tyagi, A.; Chelliah, R.; Banan-Mwine Daliri, E.; Sultan, G.; Madar, I.H.; Kim, N.; Shabbir, U.; Oh, D.-H. Antioxidant activities of novel peptides from Limosilactobacillus reuteri fermented brown rice: A combined in vitro and in silico study. Food Chem. 2023, 404, 134747. [Google Scholar] [CrossRef] [PubMed]
  27. Rai, Y.; Pathak, R.; Kumari, N.; Sah, D.K.; Pandey, S.; Kalra, N.; Soni, R.; Dwarakanath, B.S.; Bhatt, A.N. Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. Sci. Rep. 2018, 8, 1531. [Google Scholar] [CrossRef] [Green Version]
  28. Naveen, K.V.; Saravanakumar, K.; Sathiyaseelan, A.; Wang, M.-H. Preparation, characterization, and synergistic antibacterial activity of mycosynthesized, PEGylated CuO nanoparticles combined tetracycline hydrochloride. J. Drug Deliv. Sci. Technol. 2022, 76, 103826. [Google Scholar] [CrossRef]
  29. Tyagi, A.; Yeon, S.-J.; Daliri, E.B.-M.; Chen, X.; Chelliah, R.; Oh, D.-H. Untargeted metabolomics of Korean fermented Brown rice using UHPLC Q-TOF MS/MS reveal an abundance of potential dietary antioxidative and stress-reducing compounds. Antioxidants 2021, 10, 626. [Google Scholar] [CrossRef]
  30. Da Silva, M.H.R.; Cueva-Yesquén, L.G.; Júnior, S.B.; Garcia, V.L.; Sartoratto, A.; de Angelis, D.d.F.; de Angelis, D.A. Endophytic fungi from Passiflora incarnata: An antioxidant compound source. Arch. Microbiol. 2020, 202, 2779–2789. [Google Scholar] [CrossRef]
  31. Rumidatul, A.; Rahmawati, N.; Sunarya, S. Production of Secondary Metabolites and its Antibacterial and Antioxidant Activity During the Growth Period of Endophytic Fungi Isolated from Gall Rust Sengon Plants. Pharmacogn. J. 2021, 13, 325–331. [Google Scholar] [CrossRef]
  32. Lu, L.; Feng, Q.; Su, T.; Cheng, Y.; Huang, Z.; Huang, Q.; Liu, Z. Chapter 35—Pharmacoepigenetics of Chinese Herbal Components in Cancer. In Pharmacoepigenetics; Cacabelos, R., Ed.; Academic Press: Cambridge, MA, USA, 2019; Volume 10, pp. 859–869. [Google Scholar]
  33. Ali, S.; Khan, A.L.; Ali, L.; Rizvi, T.S.; Khan, S.A.; Hussain, J.; Hamayun, M.; Al-Harrasi, A. Enzyme inhibitory metabolites from endophytic Penicillium citrinum isolated from Boswellia sacra. Arch. Microbiol. 2017, 199, 691–700. [Google Scholar] [CrossRef] [PubMed]
  34. Lü, J.M.; Lin, P.H.; Yao, Q.; Chen, C. Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems. J. Cell. Mol. Med. 2010, 14, 840–860. [Google Scholar] [CrossRef] [PubMed]
  35. Platzer, M.; Kiese, S.; Herfellner, T.; Schweiggert-Weisz, U.; Miesbauer, O.; Eisner, P. Common Trends and Differences in Antioxidant Activity Analysis of Phenolic Substances Using Single Electron Transfer Based Assays. Molecules 2021, 26, 1244. [Google Scholar] [CrossRef] [PubMed]
  36. Hulikere, M.M.; Joshi, C.G.; Ananda, D.; Poyya, J.; Nivya, T. Antiangiogenic, wound healing and antioxidant activity of Cladosporium cladosporioides (Endophytic Fungus) isolated from seaweed (Sargassum wightii). Mycology 2016, 7, 203–211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Spiegel, M.; Kapusta, K.; Kołodziejczyk, W.; Saloni, J.; Żbikowska, B.; Hill, G.A.; Sroka, Z. Antioxidant activity of selected phenolic acids–ferric reducing antioxidant power assay and QSAR analysis of the structural features. Molecules 2020, 25, 3088. [Google Scholar] [CrossRef] [PubMed]
  38. Moloney, M.G. Natural Products as a Source for Novel Antibiotics. Trends Pharmacol. Sci. 2016, 37, 689–701. [Google Scholar] [CrossRef]
  39. Rempe, C.S.; Burris, K.P.; Lenaghan, S.C.; Stewart, C.N., Jr. The potential of systems biology to discover antibacterial mechanisms of plant phenolics. Front. Microbiol. 2017, 8, 422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Kapoor, G.; Saigal, S.; Elongavan, A. Action and resistance mechanisms of antibiotics: A guide for clinicians. J. Anaesthesiol. Clin. Pharmacol. 2017, 33, 300–305. [Google Scholar] [CrossRef]
  41. Pasqualetti, V.; Locato, V.; Fanali, C.; Mulinacci, N.; Cimini, S.; Morgia, A.M.; Pasqua, G.; de Gara, L. Comparison between In Vitro Chemical and Ex Vivo Biological Assays to Evaluate Antioxidant Capacity of Botanical Extracts. Antioxidants 2021, 10, 1136. [Google Scholar] [CrossRef]
  42. Butkeviciute, A.; Ramanauskiene, K.; Kurapkiene, V.; Janulis, V. Dermal Penetration Studies of Potential Phenolic Compounds Ex Vivo and Their Antioxidant Activity In Vitro. Plants 2022, 11, 1901. [Google Scholar] [CrossRef]
  43. Hardaway, C.M.; Badisa, R.B.; Soliman, K.F.A. Effect of ascorbic acid and hydrogen peroxide on mouse neuroblastoma cells. Mol. Med. Rep. 2012, 5, 1449–1452. [Google Scholar] [PubMed]
  44. Podmore, I.D.; Griffiths, H.R.; Herbert, K.E.; Mistry, N.; Mistry, P.; Lunec, J. Vitamin C exhibits pro-oxidant properties. Nature 1998, 392, 559. [Google Scholar] [CrossRef] [PubMed]
  45. Divate, R.D.; Wang, P.-M.; Wang, C.-C.; Chou, S.-T.; Chang, C.-T.; Chung, Y.-C. Protective effect of medicinal fungus Xylaria nigripes mycelia extracts against hydrogen peroxide-induced apoptosis in PC12 cells. Int. J. Immunopathol. Pharmacol. 2017, 30, 105–112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Nischitha, R.; Shivanna, M.B. Diversity and in silico docking of antibacterial potent compounds in endophytic fungus Chaetomium subaffine Sergeeva and host Heteropogon contortus (L.) P. Beauv. Process Biochem. 2022, 112, 124–138. [Google Scholar] [CrossRef]
  47. Cook, S.D. An Historical Review of Phenylacetic Acid. Plant Cell Physiol. 2019, 60, 243–254. [Google Scholar] [CrossRef]
  48. Nicoletti, R.; Fiorentino, A. Plant Bioactive Metabolites and Drugs Produced by Endophytic Fungi of Spermatophyta. Agriculture 2015, 5, 918–970. [Google Scholar] [CrossRef] [Green Version]
  49. Ikram, M.; Ali, N.; Jan, G.; Hamayun, M.; Jan, F.G.; Iqbal, A. Novel antimicrobial and antioxidative activity by endophytic Penicillium roqueforti and Trichoderma reesei isolated from Solanum surattense. Acta Physiol. Plant. 2019, 41, 164. [Google Scholar] [CrossRef]
  50. Ananda, D.; Chandrashekhar, G.J.; Sunil Kumar, R.; Heggodu, G.R.K.; Balenahalli Narasingappa, R. Antioxidant and Cytotoxic Potential of Endophytic Fungi Isolated from Medicinal Plant Tragia involucrata L. Pharmacogn. Res. 2018, 10, 188–194. [Google Scholar]
  51. Srinivasa, C.; Mellappa, G.; Patil, S.M.; Ramu, R.; Shreevatsa, B.; Dharmashekar, C.; Kollur, S.P.; Syed, A.; Shivamallu, C. Plants and endophytes—A partnership for the coumarin production through the microbial systems. Mycology 2022, 13, 243–256. [Google Scholar] [CrossRef]
  52. Brader, G.; Compant, S.; Mitter, B.; Trognitz, F.; Sessitsch, A. Metabolic potential of endophytic bacteria. Curr. Opin. Biotechnol. 2014, 27, 30–37. [Google Scholar] [CrossRef] [Green Version]
  53. El-Hawary, S.S.; Sayed, A.M.; Mohammed, R.; Hassan, H.M.; Zaki, M.A.; Rateb, M.E.; Mohammed, T.A.; Amin, E.; Abdelmohsen, U.R. Epigenetic Modifiers Induce Bioactive Phenolic Metabolites in the Marine-Derived Fungus Penicillium brevicompactum. Mar. Drugs 2018, 16, 253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Hawas, U.W.; El-Halawany, A.M.; Ahmed, E.F. Hepatitis C virus NS3-NS4A protease inhibitors from the endophytic Penicillium chrysogenum isolated from the red alga Liagora viscida. Z. Nat. C 2013, 68, 355–366. [Google Scholar]
  55. Oh, M.; Park, S.; Kim, H.; Choi, G.J.; Kim, S.H. Application of UPLC-QTOF-MS Based Untargeted Metabolomics in Identification of Metabolites Induced in Pathogen-Infected Rice. Plants 2021, 10, 213. [Google Scholar] [CrossRef] [PubMed]
  56. Dadwal, V.; Joshi, R.; Gupta, M. A comparative metabolomic investigation in fruit sections of Citrus medica L. and Citrus maxima L. detecting potential bioactive metabolites using UHPLC-QTOF-IMS. Food Res. Int. 2022, 157, 111486. [Google Scholar] [CrossRef] [PubMed]
  57. Prabhavathi, H.; Dasegowda, K.R.; Renukananda, K.H.; Karunakar, P.; Lingaraju, K.; Raja Naika, H. Molecular docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents. J. Biomol. Struct. Dyn. 2022, 40, 4713–4724. [Google Scholar] [CrossRef]
Figure 1. Antibacterial activity of the EAE-PL and EAE-PR against B. cereus (a), S. aureus (b), L. monocytogenes (c), E. coli (d), and S. enterica (e) in the disc diffusion assay. I (500 µg/mL) and II (1000 µg/mL) are the EAE-PL treatments. III (500 µg/mL) and IV (1000 µg/mL) are the EAE-PR treatments. V (100 µg/mL) is the experimental control (erythromycin (Ery)).
Figure 1. Antibacterial activity of the EAE-PL and EAE-PR against B. cereus (a), S. aureus (b), L. monocytogenes (c), E. coli (d), and S. enterica (e) in the disc diffusion assay. I (500 µg/mL) and II (1000 µg/mL) are the EAE-PL treatments. III (500 µg/mL) and IV (1000 µg/mL) are the EAE-PR treatments. V (100 µg/mL) is the experimental control (erythromycin (Ery)).
Antioxidants 12 00248 g001
Figure 2. Cell viability analysis of HEK-293 cells against the EAE-PL and EAE-PR using an MTT assay (a) and a florescent staining assay (bd), where the AO/EB dual staining (b), Rh-123 (c), and DCFH-DA (d) staining examinations were performed with a 50 µm scale bar. Error bars represent the SD of 3 independent experiments, and superscripts on error bars represent significance (p < 0.05) among the samples.
Figure 2. Cell viability analysis of HEK-293 cells against the EAE-PL and EAE-PR using an MTT assay (a) and a florescent staining assay (bd), where the AO/EB dual staining (b), Rh-123 (c), and DCFH-DA (d) staining examinations were performed with a 50 µm scale bar. Error bars represent the SD of 3 independent experiments, and superscripts on error bars represent significance (p < 0.05) among the samples.
Antioxidants 12 00248 g002
Figure 3. Analysis of the cytoprotective effect of the EAE-PL and EAE-PR in HEK-293 cells against H2O2 stress using an MTT assay (a), light microscopy (b), and a florescent staining assay (c,d), where the light microscopy (b), PI (c), and DCFH-DA (d) staining examinations were performed with a 50 µm scale bar. Error bars represent the SD of 3 independent experiments and superscripts on error bars represent significance (p < 0.05) among the groups.
Figure 3. Analysis of the cytoprotective effect of the EAE-PL and EAE-PR in HEK-293 cells against H2O2 stress using an MTT assay (a), light microscopy (b), and a florescent staining assay (c,d), where the light microscopy (b), PI (c), and DCFH-DA (d) staining examinations were performed with a 50 µm scale bar. Error bars represent the SD of 3 independent experiments and superscripts on error bars represent significance (p < 0.05) among the groups.
Antioxidants 12 00248 g003
Figure 4. The principal component analysis (PCA) of the EAE-PL and EAE-PR by comparing PC1 with PC2 (a) and the heatmap of the metabolites (levels) tentatively identified in the EAE-PL and EAE-PR samples from red to blue in descending order (b).
Figure 4. The principal component analysis (PCA) of the EAE-PL and EAE-PR by comparing PC1 with PC2 (a) and the heatmap of the metabolites (levels) tentatively identified in the EAE-PL and EAE-PR samples from red to blue in descending order (b).
Antioxidants 12 00248 g004
Figure 5. Scatter plot of the KEGG pathway analysis of differentially regulated metabolites present in EAE-PL (a) and EAE-PR (b). The X-axis denotes the Rich Factor (the ratio of the number of differentially regulated metabolites annotated in a pathway indicated on the Y-axis), and the Y-axis denotes the name of the pathways. The color of the bubbles represents the significance of the regulation at the magnitude of the p-value.
Figure 5. Scatter plot of the KEGG pathway analysis of differentially regulated metabolites present in EAE-PL (a) and EAE-PR (b). The X-axis denotes the Rich Factor (the ratio of the number of differentially regulated metabolites annotated in a pathway indicated on the Y-axis), and the Y-axis denotes the name of the pathways. The color of the bubbles represents the significance of the regulation at the magnitude of the p-value.
Antioxidants 12 00248 g005
Figure 6. The structural overlay and 3D (a,c), and 2D (b,d) docking simulation of thiophene A with the crystal structure of α-amylase (a,b) and α-glucosidase (c,d) during in silico molecular interaction analysis. The 3D simulations represent target proteins (thick tubes), ligands (thin tubes), and interaction forces/bonds (dotted tubes).
Figure 6. The structural overlay and 3D (a,c), and 2D (b,d) docking simulation of thiophene A with the crystal structure of α-amylase (a,b) and α-glucosidase (c,d) during in silico molecular interaction analysis. The 3D simulations represent target proteins (thick tubes), ligands (thin tubes), and interaction forces/bonds (dotted tubes).
Antioxidants 12 00248 g006
Figure 7. The structural overlay and 3D (a,c), and 2D (b,d) docking simulation of thiophene A with the crystal structure of NADPH oxidase (a,b) and D-alanine D-alanine ligase (c,d) during in silico molecular interaction analysis. The 3D simulations represent target proteins (thick tubes), ligands (thin tubes), and interaction forces/bonds (dotted tubes).
Figure 7. The structural overlay and 3D (a,c), and 2D (b,d) docking simulation of thiophene A with the crystal structure of NADPH oxidase (a,b) and D-alanine D-alanine ligase (c,d) during in silico molecular interaction analysis. The 3D simulations represent target proteins (thick tubes), ligands (thin tubes), and interaction forces/bonds (dotted tubes).
Antioxidants 12 00248 g007
Table 1. Analysis of the total yield, total phenolic content, and total flavonoid content of the EAE-PL and EAE-PR. The superscripts represent significance (p < 0.05) among samples.
Table 1. Analysis of the total yield, total phenolic content, and total flavonoid content of the EAE-PL and EAE-PR. The superscripts represent significance (p < 0.05) among samples.
SampleExtract Yield (%)Total Phenolic Content
(mg of GAE/g DW)
Total Flavonoid Content
(mg of QE/g DW)
EAE-PL0.41 ± 0.08 a17.89 ± 1.63 a3.31 ± 0.96 a
EAE-PR0.63 ± 0.05 b119.87 ± 3.74 b16.26 ± 1.95 b
Table 2. Antioxidant activities and diabetes-related enzyme inhibitory activities of the EAE-PL and EAE-PR compared to ascorbic acid (AA) and acarbose (AC), respectively. ND, not determined. The superscripts represent significance (p < 0.05) among samples.
Table 2. Antioxidant activities and diabetes-related enzyme inhibitory activities of the EAE-PL and EAE-PR compared to ascorbic acid (AA) and acarbose (AC), respectively. ND, not determined. The superscripts represent significance (p < 0.05) among samples.
SampleHalf-Maximal Inhibitory Concentration (IC50; µg/mL)
α-amylase Inhibitionα-glucosidase InhibitionABTS+ Radical ScavengingDPPH Radical ScavengingFerric-Reducing PowerPeroxyl Radical Scavenging
EAE-PL>1000 c>1000 c59.5 ± 1.54 c>1000 c733.3 ± 2.61 c>1000 c
EAE-PR362.5 ± 2.50 b525 ± 1.38 b37.5 ± 3.46 a187.5 ± 3.92 a175.0 ± 1.46 a532.36 ± 2.52 b
AANDND49.25 ± 2.10 b241.6 ± 1.95 b326.5 ± 3.78 b521.86 ± 1.75 a
AC37.5 ± 2.3 a87.5 ± 2.58 aNDNDNDND
Table 3. Summary of the antibacterial activity of the EAE-PL and EAE-PR against Gram-positive and Gram-negative pathogens compared to the standard antibiotic erythromycin (Ery) in the disc diffusion assay. The superscripts followed by the value represent significance (p < 0.05) among the groups.
Table 3. Summary of the antibacterial activity of the EAE-PL and EAE-PR against Gram-positive and Gram-negative pathogens compared to the standard antibiotic erythromycin (Ery) in the disc diffusion assay. The superscripts followed by the value represent significance (p < 0.05) among the groups.
Bacterial StrainsZone of Inhibition (mm)
EAE-PL (µg/mL)EAE-PR (µg/mL)Ery
(100 µg/mL)
50010005001000
B. cereus9 ± 0.5 b11.5 ± 1.0 d14 ± 0.3 c19 ± 1.5 b22 ± 1.5 b
S. aureus08 ± 0.3 a11 ± 0.1 a18 ± 0.5 a22 ± 0.3 b
L. monocytogenes09 ± 0.2 b15 ± 0.5 d19 ± 1.5 b21 ± 1.0 a
E. coli6.5 ± 0.2 a11.5 ± 0.5 e17 ± 0.1 e19 ± 1.0 b22 ± 0.5 b
S. enterica010 ± 0.3 c13 ± 0.2 b18 ± 0.5 a21 ± 0.8 a
Table 4. Determination of the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the EAE-PL and EAE-PR against Gram-positive and Gram-negative pathogens using a microtiter assay. The superscripts followed by the value represent significance (p < 0.05) among samples.
Table 4. Determination of the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the EAE-PL and EAE-PR against Gram-positive and Gram-negative pathogens using a microtiter assay. The superscripts followed by the value represent significance (p < 0.05) among samples.
Bacterial StrainsMIC (µg/mL)MBC (µg/mL)
EAE-PLEAE-PREAE-PLEAE-PR
B. cereus62.5 a31.25 a500 a125 a
S. aureus500 d125 c1000 b500 c
L. monocytogenes500 d31.25 a1000 b125 a
E. coli125 b62.5 b500 a250 b
S. enterica250 c62.5 b1000 b250 b
Table 5. Metabolite profiling of the ethyl acetate extract of Penicillium lanosum (EAE-PL) by LC-MS/MS analysis. RT, retention time.
Table 5. Metabolite profiling of the ethyl acetate extract of Penicillium lanosum (EAE-PL) by LC-MS/MS analysis. RT, retention time.
S.No.RT (min)Tentatively Identified
Compounds
FormulaMolecular WeightFound at MassAreaAdduct/Charge
1.1.23Nicotinic AcidC6H5NO2123.03215124.03882.2 × 106[M+H]+
2.1.64Succinic anhydrideC4H4O3100.01648101.02332.4 × 105[M+H]+
3.2.03MyrceneC10H16136.12567137.13243.0 × 104[M+H]+
4.3.332-MethoxyresorcinolC7H8O3140.04776141.05443.4 × 106[M+H]+
5.5.17Sorbic AcidC6H8O2112.05289113.05971.1 × 106[M+H]+
6.6.42Dihydro-beta-tubaic acidC13H16O4236.10549237.11244.6 × 105[M+H]+
7.7.35TrigonellineC7H7NO2137.04816138.0555.7 × 105[M+H]+
8.9.12SinapaldehydeC11H12O4208.07402209.08094.5 × 105[M+H]+
9.9.15RadicininC12H12O5236.06843237.07511.1 × 106[M+H]+
10.9.36AcetophenoneC8H8O120.05784121.06454.3 × 106[M+H]+
11.10.91Vanillyl alcoholC8H10O3154.06361155.07033.9 × 106[M+H]+
12.11.41p-Hydroxyphenylacetic acidC8H8O3152.04762153.05432.8 × 107[M+H]+
13.11.51Penicillic acidC8H10O4170.05863169.0511.7 × 105[M-H]-
14.13.083-Phenylpropionic acidC9H10O2150.06885151.07557.1 × 105[M+H]+
15.13.36Phenylacetic acidC8H8O2136.05302137.05985.3 × 105[M+H]+
16.14.47ValacyclovirC13H20N6O4324.15505325.16157.2 × 106[M+H]+
17.15.85Ferulic acidC10H10O4194.05872195.06551.2 × 106[M+H]+
18.16.54EugenolC10H12O2164.08434165.0911.0 × 106[M+H]+
19.16.61EpicatechinC15H14O6290.07957291.08661.2 × 106[M+H]+
20.16.77ButylphthalideC12H14O2190.10013191.10681.7 × 106[M+H]+
Table 6. Metabolite profiling of the ethyl acetate extract of Penicillium radiatolobatum (EAE-PR) by LC-MS/MS analysis. RT, retention time.
Table 6. Metabolite profiling of the ethyl acetate extract of Penicillium radiatolobatum (EAE-PR) by LC-MS/MS analysis. RT, retention time.
S.No.RT (min)Tentatively Identified
Compounds
FormulaMolecular WeightFound at MassAreaAdduct/Charge
1.0.88Salicyluric acidC9H9NO4195.05402196.06071.9 × 105[M+H]+
2.2.4LimoneneC10H16136.12562137.13251.1 × 105[M+H]+
3.2.59Thiophene AC13H8S196.03571197.04244.8 × 105[M+H]+
4.3.44ZeatinC10H13N5O219.11283220.11949.0 × 105[M+H]+
5.5.17Sorbic AcidC6H8O2112.05289113.05972.5 × 105[M+H]+
6.6.823-Indoleacetic acidC10H9NO2175.06414176.07086.2 × 105[M-H]-
7.7.938-HydroxyquinolineC9H7NO145.05328146.064.7 × 105[M+H]+
8.8.13MaculosinC14H16N2O3260.11727261.12381.1 × 106[M+H]+
9.8.58Dehydroacetic acidC8H8O4168.04297169.04979.0 × 105[M+H]+
10.8.68EsculetinC9H6O4178.02731179.03423.4 × 105[M+H]+
11.9.12SinapaldehydeC11H12O4208.07402209.0814.9 × 105[M+H]+
12.9.81Foetisulfide A C8H16OS3224.03749225.04385.8 × 103[M+H]+
13.10.93Haematommic acidC9H8O5196.03785197.04473.8 × 105[M+H]+
14.11.08p-Coumaric acidC9H8O3164.04811165.05471.4 × 106[M+H]+
15.12.28VanillinC8H8O3152.04761153.05422.6 × 107[M+H]+
16.12.73ScopoletinC10H8O4192.04292193.04951.3 × 107[M+H]+
17.12.76Curvulinic acidC10H10O5210.05359209.0461.3 × 106[M-H]-
18.12.89Sinapic acidC11H12O5224.06794225.07531.2 × 107[M+H]+
19.14.6Dehydrochorismic AcidC10H8O6224.03286225.03954.5 × 105[M+H]+
20.14.98HarmineC13H12N2O212.09586213.10273.4 × 105[M+H]+
21.15.014-Methoxycinnamic acidC10H10O3178.06369179.07041.3 × 106[M+H]+
22.15.84EthylparabenC9H10O3166.06370167.07051.9 × 106[M+H]+
23.15.85Ferulic acidC10H10O4194.05872195.06462.6 × 107[M+H]+
24.16.05FraxetinC10H8O5208.03726209.04398.7 × 106[M+H]+
25.16.41IsofraxidinC11H10O5222.05344221.04594.0 × 105[M-H]-
26.16.54Phenylacetic acidC8H8O2136.05302137.05981.1 × 106[M+H]+
Table 7. Free binding energies of the tentatively identified compounds from the EAE-PR within the active pockets of α-amylase (PDB: 1OSE), α-glucosidase (PDB: 5NN8), NADPH oxidase (PDB: 2CDU), and D-alanine D-alanine ligase (PDB: 2PVP) during the in silico molecular docking analysis. ND, not determined.
Table 7. Free binding energies of the tentatively identified compounds from the EAE-PR within the active pockets of α-amylase (PDB: 1OSE), α-glucosidase (PDB: 5NN8), NADPH oxidase (PDB: 2CDU), and D-alanine D-alanine ligase (PDB: 2PVP) during the in silico molecular docking analysis. ND, not determined.
Compoundsα-amylaseα-glucosidaseNADPH OxidaseD-alanine D-alanine
Ligase
3-Indoleacetic acid−8.77−9.60−8.88−9.11
4-Methoxycinnamic acid−8.28−8.06−8.80−9.17
8-Hydroxyquinoline−8.35−8.85−8.47−9.04
Curvulinic acid−8.07−8.63−8.59−9.04
Dehydroacetic acid−6.54−6.99−7.33−6.87
Dehydrochorismic Acid−7.59−8.39−8.05−8.51
Esculetin−8.22−8.14−8.15−8.39
Ethylparaben−8.50−8.43−8.33−8.79
Ferulic acid−7.85−8.65−8.53−8.93
Foetisulfide A −8.31−9.73−8.99−10.39
Fraxetin−7.95−7.70−7.80−8.13
Haematommic acid−9.00−8.52−7.86−8.36
Harmine−8.14−8.06−8.27−8.08
Isofraxidin−7.99−8.03−8.10−7.72
Limonene−8.78−10.17−9.65−12.40
Maculosin−8.75−8.83−9.28−8.75
p-Coumaric acid−8.51−9.75−9.06−9.25
Phenylacetic acid−8.75−9.99−8.87−10.61
Salicyluric acid−8.34−8.63−8.70−9.26
Scopoletin−7.60−7.28−8.27−8.05
Sinapaldehyde−7.87−8.39−8.80−8.60
Sinapic acid−8.54−7.84−8.59−8.45
Sorbic Acid−7.99−9.57−7.73−9.09
Thiophene A−9.75−11.74−10.96−12.06
Vanillin−7.29−8.09−7.81−8.12
Zeatin−7.85−7.91−7.64−7.87
Acarbose−6.81−7.52NDND
Ascorbic acidNDND−7.47ND
Erythronolide A (Ery)NDNDND−9.07
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Naveen, K.V.; Saravanakumar, K.; Sathiyaseelan, A.; Wang, M.-H. Comparative Analysis of the Antioxidant, Antidiabetic, Antibacterial, Cytoprotective Potential and Metabolite Profile of Two Endophytic Penicillium spp. Antioxidants 2023, 12, 248. https://doi.org/10.3390/antiox12020248

AMA Style

Naveen KV, Saravanakumar K, Sathiyaseelan A, Wang M-H. Comparative Analysis of the Antioxidant, Antidiabetic, Antibacterial, Cytoprotective Potential and Metabolite Profile of Two Endophytic Penicillium spp. Antioxidants. 2023; 12(2):248. https://doi.org/10.3390/antiox12020248

Chicago/Turabian Style

Naveen, Kumar Vishven, Kandasamy Saravanakumar, Anbazhagan Sathiyaseelan, and Myeong-Hyeon Wang. 2023. "Comparative Analysis of the Antioxidant, Antidiabetic, Antibacterial, Cytoprotective Potential and Metabolite Profile of Two Endophytic Penicillium spp." Antioxidants 12, no. 2: 248. https://doi.org/10.3390/antiox12020248

APA Style

Naveen, K. V., Saravanakumar, K., Sathiyaseelan, A., & Wang, M. -H. (2023). Comparative Analysis of the Antioxidant, Antidiabetic, Antibacterial, Cytoprotective Potential and Metabolite Profile of Two Endophytic Penicillium spp. Antioxidants, 12(2), 248. https://doi.org/10.3390/antiox12020248

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop